|
Volumn 20, Issue 18, 2010, Pages 5480-5483
|
Substituted biaryl pyrazoles as sodium channel blockers
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Biaryl pyrazoles; Chung model; Nav1.7 blockers; Neuropathic pain; Voltage gated sodium channel
|
Indexed keywords
AMIDE;
AMITRIPTYLINE;
BIPHENYL 5 CARBOXAMIDE 1H PYRAZOLE;
BIPHENYL PYRAZOLE CARBOXAMIDE;
CARBAMAZEPINE;
DILTIAZEM;
GABAPENTIN;
LAMOTRIGINE;
LIDOCAINE;
MEXILETINE;
PYRAZOLE CARBOXAMIDE;
PYRAZOLE DERIVATIVE;
SODIUM CHANNEL BLOCKING AGENT;
UNCLASSIFIED DRUG;
VOLTAGE GATED SODIUM CHANNEL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AREA UNDER THE CURVE;
ARTICLE;
COMPETITIVE INHIBITION;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG DESIGN;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG STRUCTURE;
IN VITRO STUDY;
IN VIVO STUDY;
LIVER MICROSOME;
MOLECULAR WEIGHT;
NEUROPATHIC PAIN;
NONHUMAN;
RAT;
ANIMALS;
DOGS;
HAPLORHINI;
HUMANS;
MICROSOMES, LIVER;
NEURALGIA;
PYRAZOLES;
RATS;
SODIUM CHANNEL BLOCKERS;
SODIUM CHANNELS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 77956170618
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.07.080 Document Type: Article |
Times cited : (16)
|
References (22)
|